Literature DB >> 10834628

Clinical predictors of discrepancy between self-ratings and examiner ratings for negative symptoms.

J P Selten1, D Wiersma, R J van den Bosch.   

Abstract

Little is known about the awareness of negative symptoms or its correlates. The aim of this study was to examine whether a number of clinical variables can predict the discrepancy between ratings of negative symptoms made by schizophrenic patients and by an examiner. This discrepancy could provide a measure for the awareness of negative symptoms. Eighty-six schizophrenic patients used a self-rating scale for negative symptoms with items derived from the Scale for the Assessment of Negative Symptoms (SANS). A psychiatrist assessed all patients using the SANS and other instruments, including the Present State Examination (PSE) item "insight into psychotic condition." Nurses assessed all patients using the Rehabilitation Evaluation Hall and Baker (REHAB), a scale for the measurement of psychiatric disability. All measurements were repeated after 2 months. A sensitive index for the underestimation of the severity of negative symptoms was developed, the discrepancy score. Multiple regression analysis was used to examine the predictability of discrepancy scores. Since scores for SANS items were used to calculate discrepancy scores, all regression analyses were performed with the SANS summary score as a covariate. The first step was to assess the independent contribution of each variable to the prediction of discrepancy scores. The second step was to examine the predictive quality of the 19 variables together. The variables themselves failed to make an independent contribution to the prediction of discrepancy scores at both assessments. REHAB scores, for instance, contributed to the prediction of discrepancy scores at the first assessment, but not at the second. The results of the second step showed that the best model for the prediction of discrepancy scores included the variables of depression (negative association) and anxiety (positive association). The absence of an association with the PSE item suggests that the awareness of negative symptoms is not related to insight into positive symptoms. An important limitation of our study is the arbitrary method of discrepancy quantification.

Entities:  

Mesh:

Year:  2000        PMID: 10834628     DOI: 10.1016/S0010-440X(00)90047-6

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  7 in total

1.  Self-Evaluation of Negative Symptoms: A Novel Tool to Assess Negative Symptoms.

Authors:  Sonia Dollfus; Cyril Mach; Rémy Morello
Journal:  Schizophr Bull       Date:  2015-11-12       Impact factor: 9.306

2.  Screening for negative symptoms: preliminary results from the self-report version of the Clinical Assessment Interview for Negative Symptoms.

Authors:  Stephanie G Park; Katiah Llerena; Julie M McCarthy; Shannon M Couture; Melanie E Bennett; Jack J Blanchard
Journal:  Schizophr Res       Date:  2012-01-21       Impact factor: 4.939

3.  Bridge centrality network structure of negative symptoms in people with schizophrenia.

Authors:  Ling-Ling Wang; Michelle H W Tam; Karen K Y Ho; Karen S Y Hung; Jessica O Y Wong; Simon S Y Lui; Raymond C K Chan
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-08-16       Impact factor: 5.760

4.  [Negative symptoms of schizophrenic patients from the perspective of psychiatrists, patients themselves and their relatives].

Authors:  R Bottlender; M Jäger; I Kunze; C Groll; I Borski; H-J Möller
Journal:  Nervenarzt       Date:  2003-09       Impact factor: 1.214

5.  Dimensional symptom severity and global cognitive function predict subjective quality of life in patients with schizophrenia and healthy adults.

Authors:  Pamela DeRosse; George C Nitzburg; Melanie Blair; Anil K Malhotra
Journal:  Schizophr Res       Date:  2017-10-19       Impact factor: 4.939

6.  Factor Structure, Convergent, and Divergent Validity of the Prodromal Questionnaire-Negative Symptom Subscale.

Authors:  Katherine M Pierce; Seth D Maxwell; Thomas M Olino; Shanna Cooper; Lauren M Ellman
Journal:  Assessment       Date:  2020-01-19

7.  European Validation of the Self-Evaluation of Negative Symptoms (SNS): A Large Multinational and Multicenter Study.

Authors:  Sonia Dollfus; Armida Mucci; Giulia M Giordano; István Bitter; Stephen F Austin; Camille Delouche; Andreas Erfurth; W Wolfgang Fleischhacker; Larisa Movina; Birte Glenthøj; Karoline Gütter; Alex Hofer; Jan Hubenak; Stefan Kaiser; Jan Libiger; Ingrid Melle; Mette Ø Nielsen; Oleg Papsuev; Janusz K Rybakowski; Gabriele Sachs; Alp Üçok; Francesco Brando; Pawel Wojciak; Silvana Galderisi
Journal:  Front Psychiatry       Date:  2022-01-31       Impact factor: 4.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.